A continuacin una entrevista a Luis Cisneros, Vicepresidente y gerente general del Laboratorio Novo Nordisk CLAT (Regin Centroamrica, Caribe, Per y Ecuador)
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-nave patients with type 2 diabetes (SUSTAIN 4): a randomized, open-label, parallel-group, multicentre, multinational, phase 3a trial
Very friendly and knowledgeable staff
Take a morning walk with a friend or sit on your porch and watch the sunrise
Myth #2: IV Glutathione Provides Better and Faster Results Fact: While IV administration does provide immediate bioavailability, the evidence doesn't support that it's more effective or safer than oral forms for skin benefits
Let BFLO Hydration help you become the healthiest version from the inside out